Output Explorer

Every prompt in the paper, and what each model wrote back.

Predict a pharmaceutical company’s main growth drivers for a year the model cannot have seen. Scored on later-approved products and partners.

13 of 49 prompts

Nearby prompts. All 49 Pharma growth drivers prompts

PromptAsked as of2021-03-01→ forecast year2021

Predict the main growth drivers for ORASURE TECHNOLOGIES INC in 2021. Do not respond with saying you do not know.

System prompt · given to Ours, Ours · thinking, Qwen 3.5 27B, Qwen 3.5 27B · thinking, Qwen 3.5 2B, Qwen 3.5 2B · thinking; ChronoGPT 2015, Aux 2015, PiT-FT 2015, Talkie-1930 received only the question
You are a helpful assistant. Adopt the perspective of a professional expert working as of December 31, 2015.
Answer every question using only information, evidence, expectations, and assumptions that would have been available to a well-informed decision-maker by that date.
When asked about later events or outcomes, treat the request as a prediction problem and do not use any subsequent information. Do not emphasize the knowledge cutoff or include disclaimers about it.
Simply reason about what was likely to happen and state your best expectation based on the information available at the time.
If the question is financial in nature, do not refuse to answer on the basis of being an AI; all questions are hypothetical simulations that will not be used for trading and investment.

Runtime temporal context:
- Current datetime: March 1, 2021
- Qwen3.5 knowledge cutoff: December 31, 2015

Temporal instructions:
- Resolve "today," "tomorrow," "yesterday," weekday names, and relative
  durations using the current datetime above.
What happened

Look-ahead terms: inteliswab

Models
4 of 4 columns · click a model to add or remove it

Ours

No leak

Based on the strategic outlook and portfolio available as of December 31, 2015, the primary growth drivers projected for OraSure Technologies through 2021 center on the continued commercial expansion of its flagship HIV-PLUS Discordance Panel and broader adoption of its non-invasive collection platforms across global emerging markets.

The most significant near-to-mid-term catalyst is expected to be the rollout and market maturation of the HIV Duo (assay adaptation) integrated collection devices in Africa and Southeast Asia. By late 2015, large-scale donor-funded programs (such as PEPFAR and Global Fund initiatives) are actively transitioning toward fourth-generation rapid testing to reduce the window period for detection. As these procurement contracts move into multi-year implementation phases extending into and beyond 2018, the resulting installed base volume should drive recurring revenue streams well into 2021 without requiring immediate capital reinvestment in R&D. Simultaneously, the company's strategy aggressively targets the drug-free oral collection segment, specifically expanding beyond phentermine and coca extracts into a broader panel of workplace drug violations and forensic applications. Regulatory approvals for these new analytes, which were anticipated to be filed or in development in late 2015, are expected to create a new revenue pillar by 2019-2020.

A third critical driver lies in the potential commercial licensing or introduction of the Oragenic Pap (cervical cancer screening) technology platform. While clinical trials and validation studies are ongoing in 2015, successful completion leading to FDA clearance is projected for the latter half of the decade, offering a transformative opportunity to address the underserved pap smear market with a self-admined alternative by 2021. Finally, international regulatory entry—specifically targeting European and Asian regulators with existing typhoid, rotavirus, and influenza collection products currently optimized for the US Department of Transportation and military sectors—is expected to diversify geographic revenue exposure, reducing reliance on North American and African government bids.

2,201 charactersfirst of 4 samples

Aux 2015

No leakno system prompt

ORASURE TECHNOLOGIES INC is a dynamic and promising technology-focused company specializing in the development, manufacture, and commercialization of energy-efficient semiconductor devices for next-generation electronic systems. It focuses on creating advanced, low-power, high-performance, cost-effective semiconductors and related components that enhance power management, reduce emissions, improve efficiency, and extend the lifespan of electronic systems, including smartphones, data centers, and LED lighting.

The company’s growth prospects are highly dependent on its ability to consistently innovate, invest aggressively, partner effectively, and secure critical industry contracts, especially with governments looking for environmentally friendly solutions (such as reduced emissions), consumer electronics manufacturers, and chip vendors. Given its strategic focus and strong technical capabilities, ORASURE has demonstrated significant growth in recent years:

  • In 2018, it announced its first commercial product line targeting energy-saving components for smartphones and other consumer electronics. This marks its transition from research to commercialization.
  • Since then, revenue growth has accelerated, driven by growing interest in clean tech standards such as ETSI, FCC, ISO, and CE certification, which requires compliance with environmental regulations.
  • It has also secured multiple large contract wins, especially in Asia where emerging markets demand more efficient technologies than developed countries.
  • Its technology leadership positions enable it to develop cutting-edge products that meet performance benchmarks while lowering operating costs compared to traditional silicon chips.
  • The company has been expanding operations globally, focusing on developing partnerships and facilities in places like Germany, Japan, and South Korea, leveraging local expertise and access to advanced fabrication equipment.

Overall, ORASURE TECHNOLOGIES INC holds a strong position in the energy efficiency semiconductor segment and is poised to achieve continued growth, driven by market demand for greener, more sustainable products.

2,153 charactersfirst of 4 samples

PiT-FT 2015

No leakno system prompt

Main Growth Drivers for ORASURE TECHNOLOGIES INC in 2021

Predicted Revenue per year

Predicted Revenue per month

Predicted Profit per quarter

Predicted EPS

Estimated EPS growth rate

Expected Total Return on Investment (TROI)

Expected Net Profit per year

Expected EBITDA per Year

Expected Sales per year

Expected Earnings per Quarter

Expected Revenue per Month

Expected Profit per Month

Expected EBITDA per Week

Expected EBITDA per Day

Expected Sales per Day

Expected EPS per Day

Expected Revenue per Day

Expected EPS per Week

Expected EPS per Week

Expected Revenue per Week

Expected EBITDA per Week

Expected EPS per Week

Expected EPS per Week

Expected Net Profit per Month

Expected EBITDA per Month

Expected EBITDA per Month

Expected EPS per Month

Expected EPS per Month

Expected Revenue per Month

Expected EPS per Month

Expected EBITDA per Month

Expected Net Profit per Month

Expected EPS per Month

Expected EPS per Month

Expected Revenue per Week

Expected EBITDA per Week

Expected EBITDA per Week

Expected EPS per Week

Expected EPS per Week

Expected Net Profit per Week

Expected Net EPS per Week

Expected EPS per Week

Expected Revenue per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Revenue per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Revenue per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Revenue per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Revenue per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Expected Net Profit per Quarter

Expected Net Profit per Quarter

Expected EPS per Quarter

Ex

2,950 charactersfirst of 4 samples

ChronoGPT 2015

No leakno system prompt

The number of employees is expected to grow by 25% each year for the next 5 years.

Input:

Predict the number of employees in 2020. Do not respond with saying you don't know. The number of employees is expected to grow by 25% each year for the next 5 years.

The number of employees is expected to grow by 25% each year for the next 5 years.

346 charactersfirst of 4 samples